204 related articles for article (PubMed ID: 9788260)
1. Coexpression of hepatocyte growth factor and c-Met proto-oncogene product in synovial sarcoma.
Motoi T; Ishida T; Kuroda M; Horiuchi H; Oka T; Matsumoto K; Nakamura T; Machinami R
Pathol Int; 1998 Oct; 48(10):769-75. PubMed ID: 9788260
[TBL] [Abstract][Full Text] [Related]
2. Expression of c-Met receptor and hepatocyte growth factor/scatter factor in synovial sarcoma and epithelioid sarcoma.
Kuhnen C; Tolnay E; Steinau HU; Voss B; Müller KM
Virchows Arch; 1998 Apr; 432(4):337-42. PubMed ID: 9565343
[TBL] [Abstract][Full Text] [Related]
3. Functional and therapeutic relevance of hepatocyte growth factor/c-MET signaling in synovial sarcoma.
Imura Y; Nakai T; Yamada S; Outani H; Takenaka S; Hamada K; Araki N; Itoh K; Yoshikawa H; Naka N
Cancer Sci; 2016 Dec; 107(12):1867-1876. PubMed ID: 27779808
[TBL] [Abstract][Full Text] [Related]
4. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines.
Watanabe T; Tsuda M; Makino Y; Ichihara S; Sawa H; Minami A; Mochizuki N; Nagashima K; Tanaka S
Mol Cancer Res; 2006 Jul; 4(7):499-510. PubMed ID: 16849525
[TBL] [Abstract][Full Text] [Related]
5. c-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS): an mRNA expression analysis in 23 cases.
Tamborini E; Papini D; Mezzelani A; Riva C; Azzarelli A; Sozzi G; Pierotti MA; Pilotti S
Br J Cancer; 2001 Aug; 85(3):405-11. PubMed ID: 11487273
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of HGF and c-Met/HGF receptor in human bone and soft tissue tumors.
Fukuda T; Ichimura E; Shinozaki T; Sano T; Kashiwabara K; Oyama T; Nakajima T; Nakamura T
Pathol Int; 1998 Oct; 48(10):757-62. PubMed ID: 9788258
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a new human synovial sarcoma cell line, FU-SY-1, that expresses c-Met receptor and its ligand hepatocyte growth factor.
Nishio J; Iwasaki H; Ishiguro M; Ohjimi Y; Fujita C; Isayama T; Naito M; Oda Y; Kaneko Y; Kikuchi M
Int J Oncol; 2002 Jul; 21(1):17-23. PubMed ID: 12063544
[TBL] [Abstract][Full Text] [Related]
8. Differential Ki67 and bcl-2 immunoexpression in solid-glandular and spindle cell components of biphasic synovial sarcoma: a double immunostaining assessment with cytokeratin and vimentin.
Lopes JM; Nesland JM; Reis-Filho JS; Holm R
Histopathology; 2002 May; 40(5):464-71. PubMed ID: 12010367
[TBL] [Abstract][Full Text] [Related]
9. Expression of hepatocyte growth factor (HGF)/scatter factor and its receptor c-MET correlates with poor prognosis in synovial sarcoma.
Oda Y; Sakamoto A; Saito T; Kinukawa N; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2000 Feb; 31(2):185-92. PubMed ID: 10685632
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor as mitogen, motogen and morphogen, and its roles in organ regeneration.
Nakamura T
Princess Takamatsu Symp; 1994; 24():195-213. PubMed ID: 8983076
[TBL] [Abstract][Full Text] [Related]
11. Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma.
Miettinen M; Limon J; Niezabitowski A; Lasota J
Am J Surg Pathol; 2001 May; 25(5):610-7. PubMed ID: 11342772
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
[TBL] [Abstract][Full Text] [Related]
13. Expression and localization of HGF and met in Wilms' tumours.
Alami J; Williams BR; Yeger H
J Pathol; 2002 Jan; 196(1):76-84. PubMed ID: 11748645
[TBL] [Abstract][Full Text] [Related]
14. Immunolocalization of hepatocyte growth factor and its receptor (c-Met) during mouse liver development.
Ishikawa KS; Masui T; Ishikawa K; Shiojiri N
Histochem Cell Biol; 2001 Nov; 116(5):453-62. PubMed ID: 11735009
[TBL] [Abstract][Full Text] [Related]
15. Synovial sarcoma. Inter-relationship of the biphasic and monophasic subtypes.
Dardick I; Ramjohn S; Thomas MJ; Jeans D; Hammar SP
Pathol Res Pract; 1991 Sep; 187(7):871-85. PubMed ID: 1661412
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor in human osteoarthritic cartilage.
Pfander D; Cramer T; Weseloh G; Pullig O; Schuppan D; Bauer M; Swoboda B
Osteoarthritis Cartilage; 1999 Nov; 7(6):548-59. PubMed ID: 10558853
[TBL] [Abstract][Full Text] [Related]
17. Synovial sarcoma (SS): new perspectives supported by modern technology.
Llombart-Bosch A; Lopez-Guerrero JA; Peydro-Olaya A
Arkh Patol; 2002; 64(3):39-47. PubMed ID: 15338724
[TBL] [Abstract][Full Text] [Related]
18. Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation.
Allander SV; Illei PB; Chen Y; Antonescu CR; Bittner M; Ladanyi M; Meltzer PS
Am J Pathol; 2002 Nov; 161(5):1587-95. PubMed ID: 12414507
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.
Humphrey PA; Zhu X; Zarnegar R; Swanson PE; Ratliff TL; Vollmer RT; Day ML
Am J Pathol; 1995 Aug; 147(2):386-96. PubMed ID: 7639332
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive molecular analyses of lung adenocarcinoma with regard to the epidermal growth factor receptor, K-ras, MET, and hepatocyte growth factor status.
Onitsuka T; Uramoto H; Ono K; Takenoyama M; Hanagiri T; Oyama T; Izumi H; Kohno K; Yasumoto K
J Thorac Oncol; 2010 May; 5(5):591-6. PubMed ID: 20150826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
